CS222663B2 - Method of making the new n-aryl-n-/4-piperidyl/-arylacetamide - Google Patents

Method of making the new n-aryl-n-/4-piperidyl/-arylacetamide Download PDF

Info

Publication number
CS222663B2
CS222663B2 CS766139A CS613976A CS222663B2 CS 222663 B2 CS222663 B2 CS 222663B2 CS 766139 A CS766139 A CS 766139A CS 613976 A CS613976 A CS 613976A CS 222663 B2 CS222663 B2 CS 222663B2
Authority
CS
Czechoslovakia
Prior art keywords
base
parts
group
physiologically acceptable
phenyl
Prior art date
Application number
CS766139A
Other languages
Czech (cs)
English (en)
Inventor
Stefan Sanczuk
Hubert Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CS222663B2 publication Critical patent/CS222663B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS766139A 1975-09-23 1976-09-22 Method of making the new n-aryl-n-/4-piperidyl/-arylacetamide CS222663B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
CS222663B2 true CS222663B2 (en) 1983-07-29

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
CS766139A CS222663B2 (en) 1975-09-23 1976-09-22 Method of making the new n-aryl-n-/4-piperidyl/-arylacetamide

Country Status (29)

Country Link
JP (1) JPS6016417B2 (da)
AT (1) AT363935B (da)
AU (1) AU510029B2 (da)
BG (1) BG27543A3 (da)
CA (1) CA1068271A (da)
CH (1) CH628623A5 (da)
CS (1) CS222663B2 (da)
DE (1) DE2642856A1 (da)
DK (1) DK150478C (da)
ES (1) ES451768A1 (da)
FI (1) FI61482C (da)
FR (1) FR2325377A1 (da)
GB (1) GB1539473A (da)
GR (1) GR58469B (da)
HU (1) HU172964B (da)
IE (1) IE43802B1 (da)
IL (1) IL50522A (da)
IT (1) IT1073893B (da)
LU (1) LU75837A1 (da)
NL (1) NL187267C (da)
NO (1) NO147672C (da)
NZ (1) NZ181972A (da)
PH (1) PH12497A (da)
PL (2) PL117323B1 (da)
PT (1) PT65631B (da)
RO (1) RO70079A (da)
SE (1) SE427839B (da)
SU (1) SU747424A3 (da)
YU (1) YU39973B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (da) 1980-04-18
HU172964B (hu) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (ro) 1982-10-26
LU75837A1 (da) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (da) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (da) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14
AT363935B (de) 1981-09-10

Similar Documents

Publication Publication Date Title
US4656181A (en) Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JP4754494B2 (ja) N−[フェニル(アルキルピペリジン−2−イル)メチル]ベンズアミド誘導体、この調製方法およびこの治療法における使用
DE69806141T2 (de) Indazoleamid-verbindungen als serotoninergene mittel
DE1445080B2 (de) 1-(gamma-benzoylpropyl)-4-phenylpiperidin-4-carbonsaeureamide und verfahren zu ihrer herstellung
CS222663B2 (en) Method of making the new n-aryl-n-/4-piperidyl/-arylacetamide
US4369184A (en) 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
Carceller et al. Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl) cyanomethyl) piperazines as PAF antagonists
JPH0283375A (ja) 2−置換ピペラジニル−2−(1,2−ベンズイソキサゾール−3−イル)酢酸誘導体
KR900006742B1 (ko) N-[(2-옥소피롤리딘-1-일)아세틸]피페라진 유도체 및 노인성 치매용 약제
Fontenla et al. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl) benzocycloalkanones as analogs of butyrophenone
US3479346A (en) N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines
HU191494B (en) Process for producing of pipridindion derivatives and medical products consisting of such preparates
US3989722A (en) 1-Aminomethyl-2,2-diaryl-cyclopropane carboxamides
JPS62198680A (ja) 1,6−ナフチリジン誘導体、その製造方法およびそれを含有する薬剤組成物
JPH02169572A (ja) ジヒドロピリジンアミド及びその生理学的に許容し得る塩
JP2006508110A (ja) 新規な2,3−ジヒドロ−4(1h)−ピリジノン誘導体、それらの製造方法およびそれらを含む医薬組成物
US3128276A (en) Optionally alpha-substituted 1-amino-2,3, or 4-(cyclohexyl/- phenyl) methylpiperidines and precursors
Yen et al. Compounds related to 4-diisopropylamino-2-phenyl-2-(2-pyridyl) butyramide. Synthesis and antiarrhythmic activity
KR102447231B1 (ko) 설폰아미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물
NO168640B (no) Analogifremgangsmaate for fremstilling av nye alfa, alfa-diaryl-4-aryl-4-hydroksy-1-piperidinbutanamid, n-oksyder
US3119813A (en) Azetidine derivatives
US4029786A (en) Morpholine derivatives for treating depression
DE2539364C3 (de) Verfahren zur Herstellung von Piperidinsulfonamiden
JPH0127062B2 (da)
KR960000073B1 (ko) 신규의 치환된 3-피페리딘아민 또는 3-아제핀아민, 그들의 제법 및 그들을 함유하는 약학적 조성물